RightFit
RecruitingNot applicable

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years to 77 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Interviews, CT scans

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer."
  • "Aim 3: Explore the impact of a culturally adapted TELESCOPE intervention delivered by bilingual patient navigators vs enhanced usual care (EUC) on the initial uptake of low-dose computed tomography (LDCT) and quality of the shared decision-making (SDM) process."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study adapts and tests phone or video coaching to help Hispanic or Latino adults at high risk for lung cancer decide about screening. Bilingual patient guides provide the coaching. The study compares it with enhanced usual care to see if it improves shared decisions and use of low-dose CT scans to check for lung cancer.

Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer. Aim 2: Assess the feasibility, acceptability, and implementation potential of the culturally adapted TELESCOPE intervention delivered by bilingual patient navigators for Hispanics. Hypothesis 1: The investigators expect a recruitment rate of ≥60%, ≥90% of Hispanic participants will complete the 1-week follow-up assessments, ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators, and ≥90% of participants and clinicians will agree or completely agree that the intervention was feasible and acceptable. Aim 3: Explore the impact of a culturally adapted TELESCOPE intervention delivered by bilingual patient navigators vs enhanced usual care (EUC) on the initial uptake of low-dose computed tomography (LDCT) and quality of the shared decision-making (SDM) process. Hypothesis 2: The investigators expect that an adapted TELESCOPE intervention will result in higher uptake of LDCT and higher SDM quality for lung cancer screening (LCS) compared to EUC.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients must identify as Hispanic or Latino and be 50 to 77 years old.
  • Patients must be able to read and speak English or Spanish. However, the trial exclusion list says people who do not speak English cannot join.
  • Patients must currently smoke or have smoked in the past. For the pilot trial, former smokers must have quit within the past 15 years.
  • Patients must have smoked at least 20 pack-years, such as 1 pack a day for 20 years.
  • For the pilot trial, patients must have a visit scheduled at a study site that is not for an urgent health problem and must not have coughed up blood in the past 2 weeks.
  • Staff interviews include primary care clinicians, clinic or nursing directors, clinic administrators at study sites, and TELESCOPE patient or nurse guides.
  • Online surveys include primary care providers at study sites or TELESCOPE study guides.
  • Staff taking part in interviews or surveys must be at least 18 and fluent in English.

Who can't join

  • For the trial: not speaking English or not identifying as Hispanic or Latino.
  • For the trial: having had lung cancer.
  • For the trial: having had a CT scan in the past 12 months.
  • For the trial: coughing up blood in the past 2 weeks.
  • For the trial: having health problems that make treatment meant to cure cancer unsuitable, as judged by the primary care provider.
  • For the trial, staff interviews, or online surveys: being unable to give informed consent, meaning agreeing to join after learning about the study.
  • Pregnancy is listed as an exclusion under online surveys.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Aim 1 (Cultural Adaptation): To be eligible, patients must: 1. Identify as Hispanic and/or Latino(a) 2. Able to read and speak in English or Spanish 3. Be 50 to 77 years of age 4. Be a current or former smoker 5. Have at least a 20-pack-year smoking history Aims 2-3 (Pilot Randomized Controlled Trial) To be eligible, patients must: * Identify as Hispanic or Latino(a) * Able to speak and read in English or Spanish * Be 50 to 77 years of age * Be a current or former smoker having quit within the past 15 years * Have at least a 20 pack-year smoking history * Be scheduled for a non-acute care visit at one of the study sites. * Not coughing up blood in the last two weeks Interviews Providers completing the semi-structured interviews will be: * A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator at one of the participating sites, or a TELESCOPE study patient navigator and nurse navigator * Age 18 or older * Fluent in English Online surveys Providers completing online PRISM construct surveys will be: * A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator * Age 18 or older * Fluent in English Exclusion Criteria: For the cluster randomized trial, excluded will be patients who: * Do not speak English * Are not Hispanic or Latino(a) * Have a history of lung cancer * Had a CT scan in the past 12 months * Has been coughing up blood in the last two weeks * Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider, * Are unable to provide informed consent Interviews Providers/administrators will be excluded if they: * Are unable to provide informed consent Online surveys * Are unable to provide informed consent * Women who are pregnant.

Study sites (1)

NJ